2018-04-12
Boston Consulting Group (BCG), one of the four major consulting companies in the world, recently released an industry analysis report, entitled Direction for the Development of the Drug Circulation Industry in China. The report noted that the drug circulation industry in China at present reveals three most important characteristics, i.e., a great number of enterprises, relatively low concentration and a dire need for optimization of industry structure; leading players active in expanding ability for comprehensive services with professional competencies yet to be improved; and constantly emerging new business formats and business models. The report summarized alignment of the drug circulation industry to international trends, the direction for its future development in China and challenges; BAHEAL Pharmaceutical Group (BPG), as a representative of innovative companies in China’s drug circulation industry, provides up- and downstream total solutions for the entire industrial chain and fully understands the future directions of the industry.